SHMT2 and neoplasm: For example, in vitro studies of hepatocellular carcinoma cells show that inhibition of SHMT2 significantly decreases tumor progression while its overexpression is insufficient to induce tumor transformation, thus suggesting that SHMT2 is involved in tumorigenesis but it is not able to start malignant transformation alone.